Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiangli Jin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Blood Pressure Monitoring|October 17, 2015
Acarbose, the α-glucosidase inhibitor, attenuates the blood pressure and splanchnic blood flow responses to meal in elderly patients with postprandial hypotension concomitant with abnormal glucose metabolismWei Qiao, Jing Li, Ying Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's diseaseJiangli Jin, Jiong Chen, Clémence Cavaillès, et al.
Frontiers in Pharmacology|April 28, 2025
Evaluation of drug-drug interaction between Suraxavir Marboxil (GP681) and itraconazole, and assessment of the impact of gene polymorphismMai Han, Gang Cui, Yan Zhao, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 16, 2023
Safety, pharmacokinetics, and pharmacodynamics of TG103, a novel long-acting GLP-1/Fc fusion protein after a single ascending dose in Chinese healthy subjectsJiangli Jin, Gang Cui, Na Mi, et al.
Pharmacology Research & Perspectives|June 15, 2026
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Highly Selective NaV1.8 Inhibitor JKN2306 in Healthy Chinese SubjectsYing Yang, Mai Han, Gang Cui, et al.
Frontiers in Pharmacology|June 27, 2024
A phase I, randomized study to evaluate the safety, tolerability, and pharmacokinetics of mefunidone in healthy subjectsMai Han, Bishan Huo, Gaoyun Hu, et al.
Clinical Epigenetics|August 22, 2021
DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A<sub>2</sub> in human vulnerable atherosclerotic plaqueJingjin Li, Xiaoping Zhang, Mengxi Yang, et al.
Ebiomedicine|March 21, 2022
Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African AmericansJoseph S Reddy, Jiangli Jin, Sarah J Lincoln, et al.
Acta Neuropathologica Communications|May 22, 2021
Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer's diseaseJoseph S Reddy, Mariet Allen, Charlotte C G Ho, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersVanessa M Colón Badillo, Joseph S Reddy, Jiangli Jin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Blood Pressure Monitoring|October 17, 2015
Acarbose, the α-glucosidase inhibitor, attenuates the blood pressure and splanchnic blood flow responses to meal in elderly patients with postprandial hypotension concomitant with abnormal glucose metabolismWei Qiao, Jing Li, Ying Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's diseaseJiangli Jin, Jiong Chen, Clémence Cavaillès, et al.
Frontiers in Pharmacology|April 28, 2025
Evaluation of drug-drug interaction between Suraxavir Marboxil (GP681) and itraconazole, and assessment of the impact of gene polymorphismMai Han, Gang Cui, Yan Zhao, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 16, 2023
Safety, pharmacokinetics, and pharmacodynamics of TG103, a novel long-acting GLP-1/Fc fusion protein after a single ascending dose in Chinese healthy subjectsJiangli Jin, Gang Cui, Na Mi, et al.
Pharmacology Research & Perspectives|June 15, 2026
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Highly Selective NaV1.8 Inhibitor JKN2306 in Healthy Chinese SubjectsYing Yang, Mai Han, Gang Cui, et al.
Frontiers in Pharmacology|June 27, 2024
A phase I, randomized study to evaluate the safety, tolerability, and pharmacokinetics of mefunidone in healthy subjectsMai Han, Bishan Huo, Gaoyun Hu, et al.
Clinical Epigenetics|August 22, 2021
DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A<sub>2</sub> in human vulnerable atherosclerotic plaqueJingjin Li, Xiaoping Zhang, Mengxi Yang, et al.
Ebiomedicine|March 21, 2022
Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African AmericansJoseph S Reddy, Jiangli Jin, Sarah J Lincoln, et al.
Acta Neuropathologica Communications|May 22, 2021
Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer's diseaseJoseph S Reddy, Mariet Allen, Charlotte C G Ho, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersVanessa M Colón Badillo, Joseph S Reddy, Jiangli Jin, et al.
Pageof 1